SUMMARY Nine patients with stable angna (group 1) underwent maximal treadmill stress testing and thallium-201 (201TI) myocardial scintigraphy after intravenous propranolol hydrochloride, and after placebo. Though seven of the nine patients exercised longer after propranolol than after placebo, this difference did not reach statistical significance. Propranolol, however, significantly reduced the mean maximum rate pressure product. Comparison of the perfusion scans on and off propranolol showed that in 36 out of 90 of the myocardial segments recorded (nine patients, five segments scanned twice per patient), only one of the scans showed a defect. In 24 out of 36 of these the propranolol scan was negative, the defect appearing in the placebo scan. Defects present on both scans but differing significantly in size occurred in 22 out of 54 view pairs (nine patients, three views after exercise and three views after redistribution on propranolol and on placebo), and in 19 of these the smaller defect was seen in the propranolol scan. In one of the nine patients, the propranolol scan was normal (false negative), whereas defects corresponding to angiographically proven coronary artery lesions were seen on the placebo scan.
The majority of patients undergoing 201 thallium (20lTl) myocardial perfusion imaging have actual or suspected ischaemic heart disease and many are therefore being treated with beta adrenergic blocking agents. Recent tissue sampling on dogs without coronary artery disease has suggested that propranolol may decrease myocardial uptake of 201T1 by 11 to 320/ol 2 though other workers have not found this. 3 Despite the large numbers of patients taking beta blockers who undergo 201TI scanning, there are no reports of the effects of these drugs on myocardial perfusion as represented by the 201TI images in human subjects with coronary artery disease.
The aims of this study are threefold: (1) to investigate the effects of propranolol on the distribution of 201TI in the myocardium of patients with ischaemic disease as determined by external imaging. Accepted for publication 7 October 1982 investigate if such effects are related to changes in exercise capacity induced by the drug. (3) To determine whether 201T1 scanning is best performed with the patient taking propranolol or after its temporary discontinuation.
Patients and methods
Twelve patients with stable angina pectoris were studied. The patients were all men, aged 36 to 58 years (mean 49-2 + 7.3 years) ( The rate pressure product was calculated from heart rate and mean blood pressure (diastolic + one third pulse pressure). All exercise tests were performed by the same personnel using the same equipment at the same time of day and day of week for each subject. All subjects were in the postabsorptive state, had not smoked for at least 18 hours, and had stopped all drugs 48 hours before stress testing. Hockings., Saltissi., Croft., Webb-Peploe group.bmj.com on October 14, 2017 -Published by http://heart.bmj.com/ Downloaded from Effect of beta adrenergic blockade on thallium-201 myocardial perfusion imaging and images containing 300 K counts were obtained in the anteroposterior, 450 left anterior oblique, and left lateral projections. Three to four hours later, patients were reimaged (redistribution scan) without further administration of 201Tl using the same views.
A single nine point smooth followed by empirical background subtraction were used to process the images which were then displayed on a television screen using a 15 step colour scale. Two experienced observers, uniaware both of the nature of the treadmill stress test and of the drug placebo sequence, interpreted the scans independently. In the few cases in which the observers disagreed, a concensus was reached. 
View analysis
In each view the percentage of the outer perimeter of left ventricular myocardium (excluding valve planes) represented by perfusion defects (count density <75% of maximum) was calculated by fitting a French curve to the left ventricular image and marking the defects on it. By straightening out the curve and measuring the length of the ventricular outer perimeter and of the filling defects the percentage circumferential defect for each view was measured.
Patient analysis
The scintigraphic findings in each patient whether after propranolol or placebo were analysed to determine if the scan showed fixed or reversible perfusion defects suggestive of ischaemic heart disease.
The effect of propranolol administration on the 201TI images was determined (a) by comparing the corresponding five segments of the propranolol and placebo scans for presence or absence of perfusion defects, (b) by comparing the percentage circumferential defect in each of the corresponding views (anteroposterior, left anterior oblique, and left lateral) of the propranolol and placebo scans. A difference in size between corresponding defects equal to 25% or more of the larger defect was taken to be significant. Results are expressed (where appropriate) as mean ± SEM, and exercise time (min) and rate pressure product on propranolol and placebo compared by means of Student's paired t test.
Results
Good quality myocardial images were obtained in all subjects both after exercise and on redistribution. Their coronary artery lesions are shown in Table 2 .
TREADMILL STRESS TESTING ( (Table 4) . After both propranolol and placebo seven of the nine patients displayed at least one perfusion defect allowing the correct diagnosis of ischaemic heart disease. One patient (case 8) had false negative scans after both propranolol and placebo. The last patient (case 9) had a normal scan in all views after propranolol (false negative scan), whereas the corresponding views after placebo showed anteroseptal and inferior perfusion defects correctly diagnosing ischaemic heart disease (this patient had lesions of left anterior descending and circumflex coronary arteries on angiography). In the present study, propranolol administration considerably reduced both the number and extent of 201TI perfusion defects. In 24 of the 90 segment pairs recorded (27%) a defect occurred after placebo but not after propranolol and the majority of these defects were true positives (Table 2 ) since only four (17%) occurred in areas of myocardium supplied by angiographically undiseased coronary arteries. Matched perfusion defects were also significantly smaller after propranolol compared with placebo in 19 of 54 (35%) of cases. These changes resulted in one subject having an entirely normal 201TI study on propranolol despite the presence of anterior and inferior defects on the placebo scan and angiographic left anterior descending and circumflex coronary artery disease. Scintigraphy on propranolol in this patient would have been falsely negative and the diagnosis of ischaemic heart disease missed altogether. Much less commonly the opposite changes occurred with unmatched defects being restricted to the propranolol scan or matched defects being significantly larger after its use.
Two possible mechanisms may underlie these effects. Firstly, they may result from drug induced changes in patients' exercise performance. The acute administration of propranolol7 blunts the normal rise in heart rate and systolic blood pressure occurring at each stage of upright exercise, resulting in a pronounced reduction in the rate pressure product which tends to reflect similar changes in myocardial oxygen consumption8 even in the presence of propranolol treatment.9 In addition to these effects, propranolol may also increase myocardial oxygen extraction and augment stroke volume despite a tendency for the cardiac output to fall. The overall effect of these changes on exercise ability depends on the underlying Hockings, Saltissi, Croft, Webb-Peploe left ventricular function. Normal subjects tend to perform less well after the drug, whereas patients with coronary artery disease and impaired left ventricular function show the greatest and most consistent increase in exercise performance.7 The end result in terms of the effect of propranolol on exercise 201Tl scintigraphy is that these beneficial changes may postpone the point at which myocardial ischaemia appears beyond that at which exhaustion limits the exercise test. Thus, exercise may be terminated before diagnostic perfusion defects can be induced.
In order to investigate whether changes in exercise performance and myocardial oxygen demand were responsible for the reduced diagnostic sensitivity of scanning while on propranolol, six patients (group 2) were exercised to the same rate pressure product on placebo and propranolol. Despite the fact that corresponding scans were thus obtained after exercise requiring similar degrees of myocardial oxygen consumption, 17% (10/60) of segment pairs again showed a perfusion defect on the placebo scan alone and such defects were again significantly smaller in 280/o (10/36) of view pairs after propranolol. The loss of sensitivity associated with scanning in the presence of propranolol thus seemed unrelated to the myocardial oxygen demand and hence to the principal effect of the drug on exercise performance.
The second possible underlying mechanism is a propranolol induced change in 201Tl myocardial extraction. Propranolol has been shown in resting animals without coronary artery disease to reduce Tl uptake by 11 to 32%1 2 possibly as a result of the reduction in coronary flow which often accompanies beta blockade.'0 Similar reductions in coronary flow and thallium extraction after beta blockade in man might vary substantially in degree from region to region, since flow in non-ischaemic regions that are readily accessible to the drug may be reduced to a greater extent than that in regions supplied by stenosed coronary arteries which both impede the delivery of propranolol and, as a result of atheromatous disease, tend to be less reactive to vaso-active stimuli. In this way, regional differences in 201Tl distribution which would normally result in a recognisable perfusion defect may be lessened or even obscured by treatment with propranolol. I I We believe this study has shown that 201T1 scanning in the presence of propranolol is subject to loss of sensitivity which may be manifested as a reduction in the true incidence and size of perfusion defects. As a result, the extent of disease (number of vessels involved) may be underestimated or, as in one patient in this study, the diagnosis of coronary artery disease be missed altogether. In view of these findings, it seems prudent to withdraw propranolol before performing exercise 201Tl imaging, bearing in mind poss-
